Colorectal Cancer
3rd most common cancer in the UK.
Patients present with PR Bleeding, Change in bowel habit, Tenesmus, Weight loss, Anaemia, or Obstruction.
Pathophysiology
Chromosomal Instability Pathway (Adenoma-Carcinoma Pathway) - 70% of cases - Normal mucosa → Adenoma → Invasive adenocarcinoma.
Microsatellite Instability Pathway (Serrated Pathway) - 30% of cases - Cancer arises from serrated polyps (have a serrated/saw tooth appearance microscopically).
Risk factors
Increasing age
Hereditary syndromes - FAP (Familial Adenomatous Polyposis), Lynch syndrome (Hereditary nonpolyposis colorectal cancer/HNPCC)
Long-standing IBD (10+ years)
Polyp
Diet - low fibre, high animal fat/meat/refined carbs
Familial Adenomatous Polyposis (FAP) - Autosomal dominant condition of TSG mutation where pts develop 100s of adenomatous polyps, making them virtually guaranteed to develop colorectal cancer by their 20s. This is managed with a prophylactic panproctocolectomy.
Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer/HNPCC) - Autosomal dominant condition of mismatch repair genes (MLH1/MSH2) that carries a 80% risk of developing colorectal cancer by their 30s. This is managed with regular endoscopic surveillance.
Bowel Cancer Screening Programme
The aim of this is to detect bowel cancer at an early stage, when it's easier to treat. It includes:
FIT test every 2 years for patients aged 60-74 yrs
If +ve, pt is offered a colonoscopy
Patients should be 2-week referred if:
40+ with unexplained weight loss + abdominal pain
50+ with unexplained rectal bleeding
60+ with IDA or changes in bowel habit
Proven faecal occult blood on testing
Investigations
Faecal tests:
FOB (Faecal Occult Blood) - This test picks up any type of blood present in stool, therefore will be +ve even if the patient eats red meat.
FIT (Faecal Immunochemical Test) - This test only picks up human blood, as well as inflammation. This makes it very sensitive to bowel cancer (if -ve, you can more or less rule it out).
Investigations:
Colonoscopy
Bloods - FBC, U&E, LFT, CEA
MRI for rectal cancer
Staging CT
N.B. CEA isn’t diagnostic but can be used to monitor therapeutic response to interventions.
The cancer is classified with Dukes Criteria.
Management
Bowel resection +/- adjuvant chemoradiotherapy